logo

For the Inventor, By the Inventor

Higashimatsuyama, Japan

Yukio Tada

This inventor holds 8 USPTO granted patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 1985-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukio Tada. Retrieved from https://idiyas.com/inventor/yukio-tada-u2li9bnv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Tokushima, JP (1985 - 1987)
  • Honjyo, JP (1990)
  • Higashimatsuyama, JP (1998 - 2001)

Company Filing History:

goldMedal8 out of 320 
 
Taiho Pharmaceutical Company Limited
 patents

Years Active: 1985-2001

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6294535 - Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same (2001-09-25),
2. 6159969 - Uracil derivatives, and antitumor effect potentiator and antitumor agent (2000-12-12),
3. 6110967 - Epoxysuccinamide derivative or salt thereof (2000-08-29),
4. 5883121 - Epoxysuccinamide derivative or salt thereof, and medicine comprising the (1999-03-16),
5. 5744475 - Uracil derivatives, and antitumor effect potentiator and antitumor agent (1998-04-28),
6. 4946951 - 2'-deoxy-5-fluorouridine derivatives (1990-08-07),
7. 4670583 - Amide compounds (1987-06-02),
8. 4556737 - Sulfonium compounds, processes for preparing the compounds and (1985-12-03),

Title: Innovations of Yukio Tada in Antitumor Research

Introduction

Yukio Tada is a prominent inventor based in Higashimatsuyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 8 patents to his name, Tada's work has the potential to impact cancer treatment significantly.

Latest Patents

Tada's latest patents focus on novel uracil derivatives that exhibit excellent inhibiting effects on human-derived thymidine phosphorylase and demonstrate notable anti-tumor activity. These inventions include pharmaceutical compositions, anti-tumor potentiators, and antitumor agents that incorporate these innovative compounds. The compounds are represented by specific general formulas, showcasing their unique chemical structures and potential applications in cancer therapy.

Career Highlights

Yukio Tada is currently associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing effective treatments for cancer, leveraging his expertise in medicinal chemistry and pharmacology.

Collaborations

Tada collaborates with esteemed colleagues such as Tetsuji Asao and Shingo Yano. These partnerships enhance the research and development process, fostering innovation and the sharing of ideas within the pharmaceutical community.

Conclusion

Yukio Tada's contributions to antitumor research through his innovative patents highlight his role as a key figure in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving cancer treatment options in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…